- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2059-0105
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
mRNA vaccines induce rapid antibody responses in mice ; volume:7 ; number:1 ; day:1 ; month:8 ; year:2022 ; pages:1-7 ; date:12.2022
npj vaccines ; 7, Heft 1 (1.8.2022), 1-7, 12.2022
- Creator
-
Gebre, Makda S.
Rauch, Susanne
Roth, Nicole
Gergen, Janina
Yu, Jingyou
Liu, Xiaowen
Cole, Andrew C.
Mueller, Stefan O.
Petsch, Benjamin
Barouch, Dan H.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41541-022-00511-y
- URN
-
urn:nbn:de:101:1-2022101820030700934194
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Gebre, Makda S.
- Rauch, Susanne
- Roth, Nicole
- Gergen, Janina
- Yu, Jingyou
- Liu, Xiaowen
- Cole, Andrew C.
- Mueller, Stefan O.
- Petsch, Benjamin
- Barouch, Dan H.
- SpringerLink (Online service)
Other Objects (12)
Impaired neutralizing antibody response to COVID-19 mRNA vaccines in cancer patients
Rapid development of double-hit mRNA antibody cocktail against orthopoxviruses
mRNA vaccines expressing malaria transmission-blocking antigens Pfs25 and Pfs230D1 induce a functional immune response
mRNA vaccines: A lucky shot?
Engineered Ferritin Nanoparticle Vaccines Enable Rapid Screening of Antibody Functionalization to Boost Immune Responses
Multivalent cytomegalovirus glycoprotein B nucleoside modified mRNA vaccines did not demonstrate a greater antibody breadth
The advances of adjuvants in mRNA vaccines
mRNA vaccines in disease prevention and treatment
Durable cross-protective neutralizing antibody responses elicited by lipid nanoparticle-formulated SARS-CoV-2 mRNA vaccines
Third primary SARS-CoV-2 mRNA vaccines enhance antibody responses in most patients with haematological malignancies
Self-amplifying mRNA seasonal influenza vaccines elicit mouse neutralizing antibody and cell-mediated immunity and protect ferrets
Advances in antibody-based HIV-1 vaccines development
Impaired neutralizing antibody response to COVID-19 mRNA vaccines in cancer patients
Rapid development of double-hit mRNA antibody cocktail against orthopoxviruses
mRNA vaccines expressing malaria transmission-blocking antigens Pfs25 and Pfs230D1 induce a functional immune response
mRNA vaccines: A lucky shot?
Engineered Ferritin Nanoparticle Vaccines Enable Rapid Screening of Antibody Functionalization to Boost Immune Responses
Multivalent cytomegalovirus glycoprotein B nucleoside modified mRNA vaccines did not demonstrate a greater antibody breadth
The advances of adjuvants in mRNA vaccines
mRNA vaccines in disease prevention and treatment
Durable cross-protective neutralizing antibody responses elicited by lipid nanoparticle-formulated SARS-CoV-2 mRNA vaccines
Third primary SARS-CoV-2 mRNA vaccines enhance antibody responses in most patients with haematological malignancies
Self-amplifying mRNA seasonal influenza vaccines elicit mouse neutralizing antibody and cell-mediated immunity and protect ferrets
Advances in antibody-based HIV-1 vaccines development
Impaired neutralizing antibody response to COVID-19 mRNA vaccines in cancer patients
Rapid development of double-hit mRNA antibody cocktail against orthopoxviruses
mRNA vaccines expressing malaria transmission-blocking antigens Pfs25 and Pfs230D1 induce a functional immune response
mRNA vaccines: A lucky shot?
Engineered Ferritin Nanoparticle Vaccines Enable Rapid Screening of Antibody Functionalization to Boost Immune Responses
Multivalent cytomegalovirus glycoprotein B nucleoside modified mRNA vaccines did not demonstrate a greater antibody breadth
The advances of adjuvants in mRNA vaccines
mRNA vaccines in disease prevention and treatment
Durable cross-protective neutralizing antibody responses elicited by lipid nanoparticle-formulated SARS-CoV-2 mRNA vaccines
Third primary SARS-CoV-2 mRNA vaccines enhance antibody responses in most patients with haematological malignancies
Self-amplifying mRNA seasonal influenza vaccines elicit mouse neutralizing antibody and cell-mediated immunity and protect ferrets